France · Amendment · Amendement
116
Amendement 116 — ART. 3
Introduced
26 February 2024
Last action
29 February 2024 · Rejeté
Status
Rejeté
Sponsors
—
Subjects
Discovery layer
Source updated
29 February 2024
Summary
Rédiger ainsi cet article : « Le premier alinéa de l’article L. 5122‑6 du code de la santé publique est complété par une phrase ainsi rédigée : « En outre, aucune publicité auprès du public n’est admise pour un médicament en rupture de stock ou pour lequel un risque de rupture de stock est mis en évidence. ».
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
26 February 2024
Dépôt
Source: dateDepot
27 February 2024
Publication
Source: datePublication
29 February 2024
Rejeté
Source: dateSort
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- Valérie Rabault · SOC-A · Député
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/16/amendements/AMANR5L16PO791932BTC2214P0D1N000116
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/AMANR5L16PO791932BTC2214P0D1N000116
- france · AMANR5L16PO791932BTC2214P0D1N000116 · source updated 29 February 2024